WENTWORTH KORY JAMES (Chief Financial Officer) sold 11.9% of their position (16.48K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $214.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/11/2026ACC: 0001725663-26-000003
Officer· Chief Financial Officer
Since Oct 2021
-16.48K
Net shares
Net seller
$214.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
16.48K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.09K
Price / share
$13.00
Trade value
$66.16K
% of position
3.7%
3/9/2026
137.99K→132.90K
Common Stock
Direct
Shares
−11.39K
Price / share
$13.02
Trade value
$148.22K
% of position
8.6%
3/10/2026
132.90K→121.51K
Total
Net shares
−16.48K
Net value
-$214.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2026 | S · Sale | −5.09K | $13.00 | $66.16K | 3.7% | 137.99K | 132.90K |
| Common Stock Direct | 3/10/2026 | S · Sale | −11.39K | $13.02 | $148.22K | 8.6% | 132.90K | 121.51K |
| Total | −16.48K | -$214.38K | ||||||
Derivative Transactions0
No derivative transactions reported